HAIR Restoration Robotics Inc

ARTAS iXâ„¢ Robotic Hair Restoration System to be Showcased at the 2018 World Congress of the ISHRS

ARTAS iX™ Robotic Hair Restoration System to be Showcased at the 2018 World Congress of the ISHRS

Dr. Robert Bernstein to Lead Presentation on ARTAS iX Robotic Hair Restoration System

SAN JOSE, Calif., Sept. 27, 2018 (GLOBE NEWSWIRE) -- Restoration Robotics, Inc. (NASDAQ:HAIR), the global leader in robotic hair restoration, today announced that the ARTAS iX™ Robotic Hair Restoration System will be highlighted at the 2018 World Congress of the International Society of Hair Restoration Surgery (ISHRS) in Hollywood, CA, at the Loews Hotel. ISHRS is a global non-profit medical association and the leading authority on hair loss treatment and restoration, with more than 1,200 members in 70 countries worldwide. 

"Restoration Robotics is the leading provider of cutting-edge robotic hair restoration technologies,” Ryan Rhodes, President and Chief Executive Officer of Restoration Robotics, said. “The ARTAS iX Robotic Hair Restoration System, our latest and most technologically advanced offering, represents the culmination of more than three years of research, engineering and clinical development.  We look forward to working closely with the ISHRS to further educate hair restorations surgeons on the benefits of this novel system.  The ARTAS iX System was unveiled in July 2018 and offers physicians a comprehensive solution for hair restoration that integrates robotic graft harvesting, simultaneous recipient site making and implantation.”

“The new ARTAS iX System marks a pivotal development in hair restoration technology.  I am excited to add it to my practice and to be able to offer my patients this state-of-the-art technology.” Dr. Robert M, Bernstein, MD, FAAD, FISHRS, member of the ISHRS and founder of Bernstein Medical - Center for Hair Restoration, further commented.  “This new robot is called ARTAS iX for its graft implantation capabilities, but it is so much more. The new system is faster, easier to operate, and is only half the size of the original ARTAS System.  The redesigned procedure chair has been optimized for patient comfort, and the smaller, streamlined system is compatible with a simple 120 volt outlet.”

For more information on the ARTAS iX Robotic Hair Restoration System please visit

About Restoration Robotics

Restoration Robotics, Inc., is a medical device company developing and commercializing the ARTAS™ Robotic Hair Restoration System. The ARTAS System is the first and only physician-assisted system to dissect and assist in the harvesting of follicular units directly from the scalp, create recipient implant sites using proprietary algorithms and now implant the hair follicles into the designated sites. The Company has unique expertise in machine vision, image guidance, visual servoing and robotics, as well as developing intuitive interfaces to manage these technologies.

Media Contact           

Lisa Markle 

Director of Marketing 

Restoration Robotics, Inc. 



  

Investor Contact

The Ruth Group

Brian Johnston

+1 (646) 536-7000

EN
27/09/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Restoration Robotics Inc

 PRESS RELEASE

Venus Concept Announces Fourth Quarter and Fiscal Year 2019 Financial ...

Venus Concept Announces Fourth Quarter and Fiscal Year 2019 Financial Results; Provides Preliminary First Quarter of 2020 Revenue Results and Updates Fiscal Year 2020 Revenue Guidance TORONTO, March 30, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three months and twelve months ended December 31, 2019 and preliminary revenue results for the three months ending March 31, 2020. The Company notes that the financial results provided for the three months and twelv...

 PRESS RELEASE

Venus Concept Inc. Announces $22.25 Million Equity Financing

Venus Concept Inc. Announces $22.25 Million Equity Financing TORONTO, March 18, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it entered into a definitive agreement for the sale of shares of its common stock, Series A convertible preferred stock and warrants to purchase common stock in a private placement to a group of investors, including EW Healthcare Partners, HealthQuest Capital and SEDCO Capital. The private placement is expected to result in gross proceeds to the Compa...

 PRESS RELEASE

Venus Concept to Release Fourth Quarter and Fiscal Year 2019 Financial...

Venus Concept to Release Fourth Quarter and Fiscal Year 2019 Financial Results on March 30, 2020 TORONTO, March 10, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that fourth quarter and fiscal year 2019 financial results will be released after the market closes on Monday, March 30. Management will host a conference call at 5:00 p.m. Eastern Time on March 30 to discuss the results of the quarter and the year with a question and answer session. Those who would like to participate may di...

 PRESS RELEASE

Venus Concept Expands Executive Team

Venus Concept Expands Executive Team Chad A. Zaring, Appointed Chief Commercial Officer TORONTO, March 03, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that it has expanded its Executive Team with the appointment of Chad A. Zaring to the newly-created role of Chief Commercial Officer (“CCO”), effective February 10, 2020. Mr. Zaring has extensive experience in building and executing commercial strategies and driving sales for leading surgical robotics companies in his career. “We ar...

 PRESS RELEASE

Venus Concept Inc. Announces New Regulatory Clearances

Venus Concept Inc. Announces New Regulatory Clearances CE Mark Approval for Venus Bliss™️ for Non-Invasive Lipolysis of Abdomen & Flanks, Skin Tightening, Circumferential Reduction and Cellulite ReductionHealth Canada License to Market NeoGraft 2.0 for hair restoration TORONTO, Feb. 14, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received CE Mark approval to market Venus Bliss for non-invasive lipolysis of the abdomen and flanks, skin tightening, circumferential re...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch